You are viewing: UK Structural Heart Devices Market analysis

The UK Structural Heart Devices Market was valued at $456.7 Million in 2024 and projected to reach to $736.9 Million by 2029, representing a compound annual growth rate of 10.0%. The UK structural heart devices market is positioned for sustained expansion through 2029, driven by demographic shifts and clinical innovation.

UK Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

UK Structural Heart Devices Market Trends and Insights

  • The UK market is driven by an aging population, rising prevalence of cardiac conditions, and increasing adoption of minimally invasive procedures.
  • The UK's advanced healthcare infrastructure and strong reimbursement framework support the deployment of innovative structural heart solutions, including transcatheter aortic valve replacement (TAVR), left atrial appendage (LAA) closure devices, and mitral valve repair systems. The UK market benefits from robust clinical evidence supporting structural heart interventions and growing physician expertise in catheter-based techniques.
  • The UK's National Health Service (NHS) continues to expand access to these therapies, recognizing their clinical and economic value.
  • Between 2024 and 2029, the UK market is expected to grow at a 10.0% compound annual growth rate, outpacing global trends and reflecting strong demand for less invasive alternatives to traditional cardiac surgery..

Key Market Statistics

  • CAGR (2024-2029) 10.0% CAGR
  • Market Size, 2024 ~USD 456.7 Million
  • Forecast, 2029 ~USD 736.9 Million
  • Country UK

UK Structural Heart Devices Market Overview

Market Valuation Growth :

The UK structural heart devices market is valued at $456.7 million in 2024, with a projected CAGR of 10% through 2029, reaching $736.9 million. This outpaces the global CAGR of 9.5%, indicating stronger UK market momentum.

Aging Population Driver :

The UK's aging demographic is a primary growth catalyst, with an increasing prevalence of structural heart conditions such as atrial fibrillation, mitral regurgitation, and aortic stenosis requiring intervention and device deployment.

Minimally Invasive Adoption :

UK healthcare providers are rapidly adopting minimally invasive procedures for structural heart interventions, reducing patient recovery times and hospital stays while improving clinical outcomes and cost-effectiveness.

Reimbursement & Infrastructure :

The UK's robust NHS reimbursement framework and advanced healthcare infrastructure provide strong support for structural heart device deployment, ensuring patient access and encouraging manufacturer investment in the market.

UK Structural Heart Devices Market Dynamics

  • The NHS's commitment to cardiac care, combined with increasing procedural volumes and device adoption rates, supports continued market growth.
  • Healthcare providers are investing in specialized cardiac centers and interventional capabilities, enhancing treatment accessibility across the UK. Key growth opportunities exist in transcatheter valve replacement, left atrial appendage closure, and septal defect repair technologies.
  • Regulatory support and favorable reimbursement policies create a conducive environment for new product launches.
  • As the UK population ages and awareness of structural heart conditions increases, demand for minimally invasive solutions will continue to drive market expansion through the forecast period..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • The UK structural heart devices market is valued at $456.7 million in 2024 and is forecast to reach $736.9 million by 2029, representing a 10.0% CAGR.
    • The UK market is driven by an aging population, increasing cardiac disease prevalence, and strong NHS support for minimally invasive structural heart interventions.
    • TAVR, LAA closure, and mitral valve repair devices represent the primary growth segments within the UK market.
    • The UK's advanced healthcare infrastructure and robust clinical evidence base position it as a leading European market for structural heart device adoption.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    UK Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    UK: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS80.18794.3102.2110.8120.3130.7142.18.5
    HOSPITALS574.7628.4685.1747.4815.6891974.31066.49.3
    OTHER END USERS78.586.795.4105115.7127.6140.8155.510.3
    TOTAL733.3802.2874.7954.610421138.81245.813649.3

    Target Audience

    • Medical Device Manufacturers : Device companies require UK-specific market data to assess market opportunity, competitive positioning, pricing strategies, and regulatory pathways for structural heart device launches and portfolio expansion in Britain.
    • Healthcare Investors & PE Firms : Investment professionals need detailed UK market forecasts, growth drivers, and financial projections to evaluate investment opportunities in structural heart device companies and healthcare infrastructure serving the British market.
    • NHS Hospital Trusts & Cardiac Centers : UK cardiac centers require market intelligence on device innovations, clinical evidence, reimbursement updates, and procurement trends to optimize budgeting, procurement decisions, and patient care delivery.
    • Regulatory & Health Policy Bodies : NICE, MHRA, and NHS England stakeholders need market data to inform reimbursement decisions, clinical guidelines, and health policy development for structural heart interventions across the UK.
    • Consulting & Market Research Firms : Consultants advising healthcare clients require granular UK market analysis, competitive intelligence, and forecast data to support strategic recommendations and business case development for cardiac device initiatives.

    Reasons to Buy this Report

    • UK-Specific Market Sizing : Obtain precise market valuation data exclusive to the UK, including 2024 baseline ($456.7M) and 2029 forecast ($736.9M), enabling accurate financial planning and investment decisions tailored to the British market.
    • Competitive Landscape Intelligence : Understand UK-specific competitive dynamics, market share distribution among device manufacturers, and emerging players entering the British structural heart market to inform strategic positioning.
    • NHS Reimbursement Insights : Access detailed analysis of NHS reimbursement pathways, NICE approval processes, and funding mechanisms specific to structural heart devices, critical for market entry and pricing strategies in the UK.
    • Regional Growth Drivers : Identify UK-specific growth catalysts including aging demographics, disease prevalence rates, procedural adoption trends, and healthcare infrastructure investments driving the 10% CAGR.
    • Strategic Market Entry Planning : Leverage UK market segmentation, regulatory requirements, and clinical adoption patterns to develop targeted go-to-market strategies and partnership opportunities within the British healthcare system.

    Frequently asked questions

    What is the current size of the UK structural heart devices market?

    The UK structural heart devices market was valued at $456.7 million in 2024 and is projected to grow to $736.9 million by 2029.

    What is the expected growth rate for the UK structural heart devices market?

    The UK market is expected to grow at a compound annual growth rate (CAGR) of 10.0% from 2024 to 2029.

    What are the main drivers of growth in the UK structural heart devices market?

    Key drivers include an aging population, rising prevalence of cardiac conditions, NHS support for minimally invasive procedures, and strong clinical evidence supporting structural heart interventions.

    Which structural heart devices are most commonly used in the UK?

    The UK market is dominated by transcatheter aortic valve replacement (TAVR) devices, left atrial appendage (LAA) closure devices, and mitral valve repair systems.

    How does the UK market compare to the global structural heart devices market?

    The UK market is growing at 10.0% CAGR, which exceeds the global growth rate of 9.5%, reflecting strong adoption and NHS support for structural heart therapies.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status